Thalidomide, Prednisone, and Cyclophosphamide in Treating Patients With Myelofibrosis and Myeloid Metaplasia
Status:
Completed
Trial end date:
2006-10-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Giving thalidomide together with prednisone and cyclophosphamide may lessen
symptoms caused by myelofibrosis and myeloid metaplasia.
PURPOSE: This phase II trial is studying the side effects and how well giving thalidomide
together with prednisone and cyclophosphamide works in treating patients with myelofibrosis
and myeloid metaplasia.